Gemfibrozil and Rocephin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gemfibrozil (gemfibrozil) and Rocephin (ceftriaxone sodium). Common drug interactions include sinusitis among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Gemfibrozil and Rocephin. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.
What is Gemfibrozil?
Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
51 people who take Gemfibrozil and Rocephin together, and have interactions are studied.

What are the common drug interactions of Gemfibrozil and Rocephin, by gender? *:
female:
- Sinusitis (inflammation of sinus)
- Dyspnoea (difficult or laboured respiration)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Toothache (tooth pain)
- Anaemia (lack of blood)
- Back pain
- Osteonecrosis of jaw (death of bone of jaw)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Cellulitis (infection under the skin)
- Abdominal pain
male:
- Pain
- Anaemia (lack of blood)
- Dehydration (dryness resulting from the removal of water)
- Dyspnoea (difficult or laboured respiration)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Hypotension (abnormally low blood pressure)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
What are the common drug interactions of Gemfibrozil and Rocephin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Depression
- Pain
- Anxiety
- Back pain
- Cellulitis (infection under the skin)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Death
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Obesity (having too much body fat)
- Sepsis (a severe blood infection that can lead to organ failure and death)
50-59:
- Diarrhoea
- Headache (pain in head)
- Oedema peripheral (superficial swelling)
- Arthralgia (joint pain)
- Back pain
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Gastritis (inflammation of stomach)
- Hypotension (abnormally low blood pressure)
- Impaired gastric emptying
60+:
- Dyspnoea (difficult or laboured respiration)
- Pain
- Disability
- Dizziness
- Fall
- Heart rate irregular
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Neuropathy peripheral (surface nerve damage)
- Fatigue (feeling of tiredness)
- Hypertension (high blood pressure)
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 7 people, 13.73%
- Bone Disorder: 7 people, 13.73%
- Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 9.80%
- Type 2 Diabetes: 4 people, 7.84%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.84%
- Cardiac Failure Congestive: 4 people, 7.84%
* Approximation only. Some reports may have incomplete information.
Do you take Gemfibrozil and Rocephin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gemfibrozil (18,213 reports)
- Rocephin (15,665 reports)
Browse all drug interactions of Gemfibrozil and Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gemfibrozil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemfibrozil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gemfibrozil and ceftriaxone sodium (the active ingredients of Gemfibrozil and Rocephin, respectively), and Gemfibrozil and Rocephin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tradjenta cause Alanine Aminotransferase Increased? - 11 seconds ago
- Drug interactions of Pepcid and Qulipta - 13 seconds ago
- Could Diflucan cause Abdominal Pain? - 15 seconds ago
- Could Parsabiv cause Shunt Stenosis? - 16 seconds ago
- Drug interactions of Imodium and Rivaroxaban - 17 seconds ago
- Could Warfarin Sodium cause Colonoscopy? - 18 seconds ago
- Drug interactions of Vitamins and Lasix - 19 seconds ago
- Could Veletri cause Agitation Aggravated? - 24 seconds ago
- Could Labetalol Hydrochloride cause Diarrhea? - 34 seconds ago
- Could Labetalol Hydrochloride cause Stools - Watery? - 34 seconds ago